YKL-40 can be assumed as s persuasive biomarker of diagnosis, prognosis, disease severity and activity in certain diseases, e.g. AP, chronic liver disease, AAV, RA, PA, COPD and sepsis. Here, CHI3L1 is linked to anti-neutrophil cytoplasmic antibody-associated vasculitis.